NO995681L - Fremgangsmåte for å fremstille fluorbiprofen-tabletter - Google Patents

Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Info

Publication number
NO995681L
NO995681L NO995681A NO995681A NO995681L NO 995681 L NO995681 L NO 995681L NO 995681 A NO995681 A NO 995681A NO 995681 A NO995681 A NO 995681A NO 995681 L NO995681 L NO 995681L
Authority
NO
Norway
Prior art keywords
tablets
mixture
fluorobiprofen
preparing
forming
Prior art date
Application number
NO995681A
Other languages
English (en)
Norwegian (no)
Other versions
NO995681D0 (no
Inventor
Andrew Day
Huw Lyn Jones
Carl Simon Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO995681D0 publication Critical patent/NO995681D0/no
Publication of NO995681L publication Critical patent/NO995681L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO995681A 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter NO995681L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9710521.7A GB9710521D0 (en) 1997-05-22 1997-05-22 Process
PCT/EP1998/003167 WO1998052539A1 (en) 1997-05-22 1998-05-20 Process for making flurbiprofen lozenges

Publications (2)

Publication Number Publication Date
NO995681D0 NO995681D0 (no) 1999-11-19
NO995681L true NO995681L (no) 1999-11-19

Family

ID=10812840

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995681A NO995681L (no) 1997-05-22 1999-11-19 Fremgangsmåte for å fremstille fluorbiprofen-tabletter

Country Status (31)

Country Link
US (1) US6194003B1 (enExample)
EP (1) EP0983059B1 (enExample)
JP (1) JP2001527567A (enExample)
KR (1) KR20010012739A (enExample)
CN (1) CN1154480C (enExample)
AR (1) AR015812A1 (enExample)
AT (1) ATE245021T1 (enExample)
AU (1) AU725760B2 (enExample)
BG (1) BG103881A (enExample)
BR (1) BR9809651A (enExample)
CA (1) CA2290830C (enExample)
CZ (1) CZ290816B6 (enExample)
DE (1) DE69816440T2 (enExample)
DK (1) DK0983059T3 (enExample)
ES (1) ES2202871T3 (enExample)
GB (1) GB9710521D0 (enExample)
HU (1) HU224954B1 (enExample)
ID (1) ID22949A (enExample)
IL (1) IL132999A0 (enExample)
IN (1) IN187837B (enExample)
MY (1) MY118410A (enExample)
NO (1) NO995681L (enExample)
NZ (1) NZ500664A (enExample)
PL (1) PL190947B1 (enExample)
PT (1) PT983059E (enExample)
RU (1) RU2203046C2 (enExample)
SK (1) SK283701B6 (enExample)
TR (1) TR199902725T2 (enExample)
UA (1) UA53714C2 (enExample)
WO (1) WO1998052539A1 (enExample)
ZA (1) ZA984260B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4040878B2 (ja) 1999-12-09 2008-01-30 レキット ベンキーザー ヘルスケア （ユーケイ） リミテッド 治療薬
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
JP4886107B2 (ja) * 2000-10-13 2012-02-29 サンスター株式会社 歯周病予防用口腔内溶解錠
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
WO2005065069A2 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
FR2865648B1 (fr) * 2004-02-03 2006-06-30 Philippe Perovitch Procede de diffusion de molecules insolubles en milieu aqueux et composition mettant en oeuvre ce procede
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
KR20070004036A (ko) * 2004-04-29 2007-01-05 키스톤 리테이닝 월 시스템스, 아이엔씨 벽, 옹벽 및 그 외 유사한 것을 위한 베니어
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CN103479582A (zh) 2005-02-03 2014-01-01 武田奈科明有限公司 制备含钙组合物的快速湿聚结方法
GB2423710A (en) 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
CN103622926A (zh) * 2005-11-02 2014-03-12 帝国制药美国公司 感官上可接受的布洛芬口服给药制剂、制备和使用它的方法
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
EA200901188A1 (ru) * 2007-07-23 2010-04-30 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Органолептически приемлемые дозированные лекарственные формы индольных агонистов серотониновых рецепторов для перорального применения и способы их применения
CN102131496B (zh) * 2008-08-22 2013-10-23 雷克特本克斯尔保健(英国)有限公司 组合物的改进或与组合物有关的改进
IT1397132B1 (it) 2009-12-01 2013-01-04 Alfa Wassermann Spa Composizioni comprendenti antiinfiammatori non steroidei.
IT1406107B1 (it) * 2010-12-13 2014-02-14 Alfa Wassermann Spa Composizioni solide comprendenti antiinfiammatori non steroidei, processi per la loro preparazione e loro uso.
SMT202100228T1 (it) 2011-04-29 2021-05-07 Moberg Pharma Ab Composizioni farmaceutiche comprendenti un anestetico locale come bupivacaina per somministrazione locale alla bocca o alla gola
EP2609911A1 (en) * 2011-12-29 2013-07-03 Sanovel Ilac Sanayi ve Ticaret A.S. A novel process for preparing orally disintegrating flurbiprofen formulations
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
WO2020013781A2 (en) * 2018-03-27 2020-01-16 Pisak Mehmet Nevzat Synergistic effect of flurbiprofen and a gastro protective agent for the treatment of pain and inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4666716A (en) * 1984-09-04 1987-05-19 Richardson-Vicks Inc. Antidiarrheal compositions and use thereof
RU2026670C1 (ru) * 1988-10-05 1995-01-20 Дзе Апджон Компани Способ получения тонкодисперсного твердого фармацевтического вещества
IT1243342B (it) 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
IT1244698B (it) * 1991-02-01 1994-08-08 Gentili Ist Spa Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
US5302394A (en) * 1992-07-14 1994-04-12 Mcneil-Ppc, Inc. Dextromethorphan continuous lozenge manufacturing process
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
US5614207A (en) * 1995-06-30 1997-03-25 Mcneil-Ppc, Inc. Dry mouth lozenge
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment

Also Published As

Publication number Publication date
CZ412099A3 (cs) 2000-02-16
PL336624A1 (en) 2000-07-03
ZA984260B (en) 1999-02-20
ATE245021T1 (de) 2003-08-15
CZ290816B6 (cs) 2002-10-16
BR9809651A (pt) 2000-07-11
ID22949A (id) 1999-12-16
AU725760B2 (en) 2000-10-19
SK283701B6 (sk) 2003-12-02
DE69816440T2 (de) 2004-05-13
ES2202871T3 (es) 2004-04-01
PT983059E (pt) 2003-11-28
WO1998052539A1 (en) 1998-11-26
GB9710521D0 (en) 1997-07-16
EP0983059B1 (en) 2003-07-16
EP0983059A1 (en) 2000-03-08
DE69816440D1 (de) 2003-08-21
IL132999A0 (en) 2001-03-19
HUP0002121A3 (en) 2001-04-28
US6194003B1 (en) 2001-02-27
BG103881A (bg) 2000-05-31
SK158899A3 (en) 2000-05-16
NO995681D0 (no) 1999-11-19
CA2290830C (en) 2006-07-11
MY118410A (en) 2004-10-30
NZ500664A (en) 2001-01-26
KR20010012739A (ko) 2001-02-26
AR015812A1 (es) 2001-05-30
PL190947B1 (pl) 2006-02-28
JP2001527567A (ja) 2001-12-25
CN1154480C (zh) 2004-06-23
IN187837B (enExample) 2002-06-29
DK0983059T3 (da) 2003-11-03
HU224954B1 (en) 2006-04-28
RU2203046C2 (ru) 2003-04-27
HUP0002121A2 (hu) 2000-12-28
CA2290830A1 (en) 1998-11-26
AU7916598A (en) 1998-12-11
UA53714C2 (uk) 2003-02-17
CN1255848A (zh) 2000-06-07
TR199902725T2 (xx) 2000-02-21

Similar Documents

Publication Publication Date Title
NO995681L (no) Fremgangsmåte for å fremstille fluorbiprofen-tabletter
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
RU98123589A (ru) Композиция для орального введения, способ снижения обжигающего послевкусия композиций пропионовой кислоты
DE2966767D1 (en) Carboxyalkyl dipeptide derivatives, process for preparing them and pharmaceutical composition containing them
AU7061587A (en) Controlled-release pharmaceutical composition for periodontal diseases
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
ES8602599A1 (es) Un procedimiento de preparar un derivado de trans-1,2-diaminoxiclohexil-amida.
EP0151344A3 (en) A chewing gum composition, a process for preparing a chewing gum tablet therefrom, and a chewing gum tablet
IE821861L (en) Pharmaceutical compositions
IL112957A0 (en) Thieno [2,3-b] indoles, their preparation and pharmaceutical compositions containing them
NZ510583A (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
DE3263567D1 (en) New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions
ZA871836B (en) Therapeutic agents
EP0295212A3 (en) Process for preparing a pharmaceutical composition
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DE2966706D1 (en) Substituted anthranilic acid amides, process for their preparation, pharmaceutical compositions containing them and their preparation
AU7292794A (en) A method of manufacturing a laxative composition dosage unit and dosage units obtained thereby
PT74937A (en) Process for the preparation of novel analgesic and antiinflammatory compounds and of pharmaceutical compositions containing the same
ES8604731A1 (es) Un metodo de preparar derivados de 6,11-dihidrodibenz (b,e) oxepina
KR890007745A (ko) 약학조성물 및 그의 제조방법
PT80131A (en) Process for the preparation of pharmaceutical compositions in liquid dosage form suitable for oral administration of 4'-demethylepipodophyllotoxin-9-<4,6-o(r)-ethylidene-beta-d-glucopyranoside>(etoposide)
ES8506717A1 (es) Procedimiento de preparacion de nuevos derivados de 1, 3-dihidro-6-metil-7-hidroxi-furo-(3, 4-c)-piridina
FR2769839B1 (fr) Composition anhydre a base de lactulose
DE3269449D1 (en) P-acylaminophenol derivatives with a therapeutical effect, process for their preparation, and compositions with a therapeutical effect containing these derivatives as pharmacologically active ingredients
HUT34489A (en) Process for preparing 7-oxo-4-thia-1-aza-bicyclo/3,2,0/hept-2-ene derivatives and pharmaceutical compositions containing thereof as active substances

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application